In line with this interpretation, tumor studies such as that reported by Morten et al. [33] in an Australian study on BC tissue found that tumors harboring the intronic 16 bp insertion exhibited higher full-length p53, a lower Δ40p53 mRNA ratio, and better disease-free survival. The gene discussed is TP53; the disease is breast cancer.